NEVVI Medicare utilization intelligence

← back

Provider profile

JANIGA, MATTHEW M.D.

Urology · NPI 1891912259 · AUBURN, CA

1
Groups
38
Codes · 2024
31,661
Disclosed services

JANIGA, MATTHEW is a Urology in AUBURN, CA, a member of 1 medical group, who billed 38 distinct codes to Medicare Part B in 2024.

Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

31,661
disclosed services
38
codes billed to Medicare Part B
Prior year · CY2023 15,924 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg premiumpremium premiumpremium
J9030 Bcg live intravesical instillation, 1 mg premiumpremium premiumpremium
J0585 Injection, onabotulinumtoxina, 1 unit premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
51798 Ultrasound measurement of bladder capacity after voiding premiumpremium premiumpremium
81003 Automated urinalysis test premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
52000 Diagnostic exam of bladder and urethra using an endoscope premiumpremium premiumpremium
51720 Instillation of anti-cancer drug into bladder premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
J1580 Injection, garamycin, gentamicin, up to 80 mg premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
J0696 Injection, ceftriaxone sodium, per 250 mg premiumpremium premiumpremium
74420 Imaging of urinary tract following injection of a contrast agent premiumpremium premiumpremium
55700 Biopsy of prostate gland premiumpremium premiumpremium
51700 Simple bladder irrigation and/or instillation premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
52310 Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope premiumpremium premiumpremium
52287 Exam with injections of chemical for destruction of bladder using an endoscope premiumpremium premiumpremium
52356 Crushing of stone of ureter with insertion of stent using an endoscope premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
76857 Limited ultrasound scan of pelvis premiumpremium premiumpremium
76942 Ultrasonic guidance for needle placement premiumpremium premiumpremium
0421T Waterjet destruction of prostrate accessed through the urethra premiumpremium premiumpremium
A4648 Tissue marker, implantable, any type, each premiumpremium premiumpremium
52240 Destruction and/or removal of large growth of bladder using an endoscope premiumpremium premiumpremium
55874 Injection of biodegradable material next to prostate premiumpremium premiumpremium
52001 Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope premiumpremium premiumpremium
55876 Placement of device in prostate for radiation therapy premiumpremium premiumpremium
52281 Dilation of urethra using an endoscope premiumpremium premiumpremium
52318 Crushing, fragmenting, and removal of bladder stones, more than 2.5 cm premiumpremium premiumpremium
76872 Ultrasound scan of pelvic region through rectum premiumpremium premiumpremium
52601 Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope premiumpremium premiumpremium
50590 Shock wave crushing of kidney stones premiumpremium premiumpremium
52332 Insertion of stent in ureter using an endoscope premiumpremium premiumpremium
52234 Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm premiumpremium premiumpremium
52315 Complicated removal of foreign body, stone, or stent in urethra or bladder using an endoscope premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.